Evaluation of a System for Automatic Detection of Diabetic Retinopathy From Color Fundus Photographs in a Large Population of Patients With Diabetes: Response to Olson et al. by Abràmoff, Michael D. et al.
COMMENTS AND
RESPONSES
Evaluation of a
System for Automatic
Detection of Diabetic
Retinopathy From
Color Fundus
Photographs in a
Large Population of
Patients With
Diabetes
Response to Olson et al.
W
e thank Olson et al. (1) for their
close reading of our recent study
(2),whereweexaminedsensitiv-
ity and speciﬁcity of automated diabetic
retinopathy detection and demonstrated
anareaunderthereceiveroperatingchar-
acteristic curve of 0.87. A limited, 500-
patientsampleofall10,000photographic
examswasexaminedbymultiple,masked
experts. We felt uncomfortable recom-
mending a system for clinical practice for
which patient safety compared to an ac-
cepted (gold) standard could not be es-
tablished, concluding that it should be
tested against widely accepted clinical
standards, if practical. We have recently
presented studies of an improved algo-
rithm on a new, larger dataset of 15,000
exams with an area under the curve of
0.90(3).Mostoftheseresultssupportthe
work of Olson and colleagues (4), al-
though the fact that their system only
detects small hemorrhages and microan-
eurysms is a serious limitation in our
view, and sensitivity and speciﬁcity based
upon the photographic interpretation by
a single reader is unlikely to become
widely accepted.
Failure to detect large, rare, and/or
advanced lesions deserves disproportion-
ate attention. If a patient with isolated
neovascularization of the disc, 1:5,000
in our series, were to be missed by a sys-
tem but would not have been missed by a
person, that is a failure likely to lead to
vision loss or blindness for that patient,
potentiallitigation,andabacklashagainst
implementation of automated detection.
Groups translating automated dia-
betic retinopathy detection into clinical
practice operate in environments that dif-
fer on regulatory, legal, budgetary, and
reimbursement aspects, but we disagree
that “a recommendation against auto-
mated grading is only valid if it is shown
that there is a higher performing and
readily alternative methodology” (1). The
currently established practice is human
expertreading,andtheburdenofproofis
therefore on the new system to be intro-
duced, which is automated reading. For
automatedreadingtogainwidespreadac-
ceptance, no shortcuts regarding safety
concerns will likely be permitted by reg-
ulatory agencies, payers, and patients.
Onestudy’sentrycriteriamaybeper-
ceivedasanother’sselectionbias.Thetar-
get population of the EyeCheck project
consistsofpatientswhohadnotbeenpre-
viously identiﬁed to have diabetic reti-
nopathy. In most settings, as patients are
identiﬁed with diabetic retinopathy they
are referred for evaluation or treatment,
removing them from the screened popu-
lation. To establish any other inclusion
criteria would have constituted selection,
affecting the potential application of this
data to current clinical practice.
Thepotentialpositiveeffectofcamera
resolution on algorithmic performance is
intriguing, although with less costly cam-
eras presently offering at least 1,024 
1,024 pixels, this debate may be self-
limiting. We believe that comparison of
algorithms to standardized datasets
(http://roc.healthcare.uiowa.edu) as well
as to the gold standard are required and
should include: 1) demonstration in a
prospective multicenter study of similar
or better detection; on populations with
deﬁned race and ethnicity distributions,
2) acceptable comparison of detection to
standard multiﬁeld stereo photographs
read according to the Early Treatment of
DiabeticRetinopathyStudystandard;and
3) sensitivity/speciﬁcity analysis with
standard and severity-weighted receiver
operating characteristic curves.
Insummary,weagreethatautomated
detection of diabetic retinopathy can
make the prevention of blindness and vi-
sion loss objective, more accessible, and
morecost-effective,providedsafetyissues
are not overlooked.
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